*0011145427
*008110901s2011    xx#           000 0 nob
*019  $bk
*08230$a616.462
*100  $aØfjord, Erik Snorre$4aut$_135726600
*245  $aMedikamentell forebygging ved prediabetes - ingen hensikt?
*300  $aS. 1418-1419
*650  $alegemiddelbehandling$9nor$2norart$_128631200
*650  $atype 2 diabetes$9nor$2norart$_128979300
*700  $aAarskog, Dagfinn;$4aut$_135726700
*700  $aBakken, Sjur;$4aut$_135726800
*700  $aHelberg, Steinar;$4aut$_135726900
*700  $aJacobsen, Trine;$4aut$_135727000
*700  $aJenssen, Trond$4aut$_135727100
*700  $aNasrala, Samuel;$4aut$_135727200
*700  $aRisberg, Knut;$4aut$_135727300
*700  $aSkag, Arne;$4aut$_135727400
*700  $aSyversen, Unni;$4aut$_135727500
*773  $tTidsskrift for Den norske legeforening$gÅrg. 131, nr. 15 (2011)$x0029-2001$w(NO-LaBS)552783(tnr)
*8564 $uhttps://doi.org/10.4045/tidsskr.10.1459
*999  $z1100498601$anorart:1100498601
^